<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Pharma — Oktober 2024]]></title><description><![CDATA[<p dir="auto">Danske Bank ser mulighed for mere udlodning fra Lundbeck <a href="https://proinvestor.com/investornyt/1223637/danske-bank-ser-mulighed-for-mere-udlodning-fra-lundbeck" rel="nofollow ugc">https://proinvestor.com/investornyt/1223637/danske-bank-ser-mulighed-for-mere-udlodning-fra-lundbeck</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400891/pharma-oktober-2024</link><generator>RSS for Node</generator><lastBuildDate>Sun, 07 Jun 2026 02:25:30 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400891.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 07 Oct 2024 11:31:36 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Thu, 31 Oct 2024 11:33:25 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck fremlægger positive fase 3-resultater med migrænemiddel <a href="https://proinvestor.com/investornyt/1235691/lundbeck-fremlaegger-positive-fase-3-resultater-med-migraenemiddel" rel="nofollow ugc">https://proinvestor.com/investornyt/1235691/lundbeck-fremlaegger-positive-fase-3-resultater-med-migraenemiddel</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038164</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038164</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Thu, 31 Oct 2024 11:33:25 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Wed, 30 Oct 2024 19:37:57 GMT]]></title><description><![CDATA[<p dir="auto">Amgen Inc. Q3 Profit Increases, Beats Estimates <a href="https://proinvestor.com/investornyt/1235277/amgen-inc-q3-profit-increases-beats-estimates" rel="nofollow ugc">https://proinvestor.com/investornyt/1235277/amgen-inc-q3-profit-increases-beats-estimates</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038163</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038163</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 30 Oct 2024 19:37:57 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Wed, 30 Oct 2024 04:51:02 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får løftet kursmålet til 50 kr. fra 35 kr. af Jefferies <a href="https://proinvestor.com/investornyt/1234766/lundbeck-far-loftet-kursmalet-til-50-kr-fra-35-kr-af-jefferies" rel="nofollow ugc">https://proinvestor.com/investornyt/1234766/lundbeck-far-loftet-kursmalet-til-50-kr-fra-35-kr-af-jefferies</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038165</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038165</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 30 Oct 2024 04:51:02 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 29 Oct 2024 13:21:45 GMT]]></title><description><![CDATA[<p dir="auto">Novartis i god vækst. <a href="https://www.novartis.com/sites/novartis_com/files/q3-2024-media-release-en.pdf" rel="nofollow ugc">https://www.novartis.com/sites/novartis_com/files/q3-2024-media-release-en.pdf</a> Core operating income to grow high teens. Forward EPS op fra 6.47$ til måske 7.63$. Ved en aktiekurs på 112,4$ bliver forward PE lige under 15. Også pænt.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038162</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038162</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 29 Oct 2024 13:21:45 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 29 Oct 2024 13:05:14 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer forward adjusted EPS 2,85 $ +/- 0.10. <a href="https://s28.q4cdn.com/781576035/files/doc_financials/2024/q3/Q3-2024-PFE-Earnings-Release-Final.pdf" rel="nofollow ugc">https://s28.q4cdn.com/781576035/files/doc_financials/2024/q3/Q3-2024-PFE-Earnings-Release-Final.pdf</a> Til kurs 28,5 så er PE 10. Det er da en god pris for en af verdens største Pharma virksomheder.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038167</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038167</guid><dc:creator><![CDATA[Occam]]></dc:creator><pubDate>Tue, 29 Oct 2024 13:05:14 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 29 Oct 2024 10:07:18 GMT]]></title><description><![CDATA[<p dir="auto">Eli Lilly's Latest Setback Could Portend an Unexpected Headwind for the Stock <a href="https://proinvestor.com/investornyt/1234211/eli-lillys-latest-setback-could-portend-an-unexpected-headwind-for-the-stock" rel="nofollow ugc">https://proinvestor.com/investornyt/1234211/eli-lillys-latest-setback-could-portend-an-unexpected-headwind-for-the-stock</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038159</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038159</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 29 Oct 2024 10:07:18 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 29 Oct 2024 04:23:17 GMT]]></title><description><![CDATA[<p dir="auto">AbbVie adds anti-amyloid asset to its CNS repertoire in $1.4B-buyout of Aliada <a href="https://firstwordpharma.com/story/5907150" rel="nofollow ugc">https://firstwordpharma.com/story/5907150</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038158</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038158</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 29 Oct 2024 04:23:17 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Fri, 25 Oct 2024 13:08:06 GMT]]></title><description><![CDATA[<p dir="auto">Selvom regnskabssæsonen ikke for alvor er gået i gang endnu, er der endnu en gang besøgsrekord på <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a>. Tak for at følge med! I denne pharma- og biotekopdatering kommer Helge Larsen ind på fedmesektoren, bl.a. et nyt studie fra Novo, hvor glp1 i Ozempic kan have en positiv effekt på alzheimers. Slutteligt fortæller han om Embla Medical, som laver proteser, og hvor nyeste skud på stammen er udviklet med kunstig intelligens. Kort video <a href="https://proinvestor.com/boards/122728" rel="nofollow ugc">https://proinvestor.com/boards/122728</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038161</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038161</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 25 Oct 2024 13:08:06 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Wed, 23 Oct 2024 11:20:30 GMT]]></title><description><![CDATA[<p dir="auto">L<br />
undbeck forsigtigt optimistisk omkring Rexulti-godkendelse i PTSD <a href="https://proinvestor.com/investornyt/1231375/lundbeck-forsigtigt-optimistisk-omkring-rexulti-godkendelse-i-ptsd" rel="nofollow ugc">https://proinvestor.com/investornyt/1231375/lundbeck-forsigtigt-optimistisk-omkring-rexulti-godkendelse-i-ptsd</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038160</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038160</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 23 Oct 2024 11:20:30 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Wed, 23 Oct 2024 09:53:53 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck-topchef har fundet mange svar på fremtidens udfordringer over det seneste år <a href="https://proinvestor.com/investornyt/1231302/lundbeck-topchef-har-fundet-mange-svar-pa-fremtidens-udfordringer-over-det-seneste-ar" rel="nofollow ugc">https://proinvestor.com/investornyt/1231302/lundbeck-topchef-har-fundet-mange-svar-pa-fremtidens-udfordringer-over-det-seneste-ar</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038154</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038154</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 23 Oct 2024 09:53:53 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Wed, 23 Oct 2024 09:07:52 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck opdaterer langsigtet prognose før kapitalmarkedsdag og annoncerer nedskrivning <a href="https://proinvestor.com/investornyt/1231202/lundbeck-opdaterer-langsigtet-prognose-for-kapitalmarkedsdag-og-annoncerer-nedskrivning" rel="nofollow ugc">https://proinvestor.com/investornyt/1231202/lundbeck-opdaterer-langsigtet-prognose-for-kapitalmarkedsdag-og-annoncerer-nedskrivning</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038156</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038156</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 23 Oct 2024 09:07:52 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Wed, 23 Oct 2024 02:42:14 GMT]]></title><description><![CDATA[<p dir="auto">FDA Okays Pfizer's RSV Vaccine ABRYSVO For Adults Aged 18 To 59 At Increased Risk For Disease <a href="https://proinvestor.com/investornyt/1231139/fda-okays-pfizers-rsv-vaccine-abrysvo-for-adults-aged-18-to-59-at-increased-risk-for-disease" rel="nofollow ugc">https://proinvestor.com/investornyt/1231139/fda-okays-pfizers-rsv-vaccine-abrysvo-for-adults-aged-18-to-59-at-increased-risk-for-disease</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038151</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038151</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Wed, 23 Oct 2024 02:42:14 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 22 Oct 2024 11:12:07 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck må fortsat forsvare sig i bedragerisag i USA <a href="https://proinvestor.com/investornyt/1230700/lundbeck-ma-fortsat-forsvare-sig-i-bedragerisag-i-usa" rel="nofollow ugc">https://proinvestor.com/investornyt/1230700/lundbeck-ma-fortsat-forsvare-sig-i-bedragerisag-i-usa</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038155</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038155</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 22 Oct 2024 11:12:07 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 22 Oct 2024 04:30:15 GMT]]></title><description><![CDATA[<p dir="auto">Leo Pharma snupper IR-chef fra Danske Bank før mulig børsnotering <a href="https://proinvestor.com/investornyt/1230521/leo-pharma-snupper-ir-chef-fra-danske-bank-for-mulig-borsnotering" rel="nofollow ugc">https://proinvestor.com/investornyt/1230521/leo-pharma-snupper-ir-chef-fra-danske-bank-for-mulig-borsnotering</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038148</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038148</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 22 Oct 2024 04:30:15 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Fri, 18 Oct 2024 06:01:31 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får løftet kursmålet hos Handelsbanken <a href="https://proinvestor.com/investornyt/1228940/lundbeck-far-loftet-kursmalet-hos-handelsbanken" rel="nofollow ugc">https://proinvestor.com/investornyt/1228940/lundbeck-far-loftet-kursmalet-hos-handelsbanken</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038152</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038152</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 18 Oct 2024 06:01:31 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Tue, 15 Oct 2024 06:17:05 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck får løftet kursmål hos DNB <a href="https://proinvestor.com/investornyt/1227131/lundbeck-far-loftet-kursmal-hos-dnb" rel="nofollow ugc">https://proinvestor.com/investornyt/1227131/lundbeck-far-loftet-kursmal-hos-dnb</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038150</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038150</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 15 Oct 2024 06:17:05 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Mon, 14 Oct 2024 13:24:49 GMT]]></title><description><![CDATA[<p dir="auto">Jefferies kalder Lundbecks opkøb for større end ventet - både i størrelse og på potentiale <a href="https://proinvestor.com/investornyt/1226809/jefferies-kalder-lundbecks-opkob-for-storre-end-ventet-bade-i-storrelse-og-pa-potentiale" rel="nofollow ugc">https://proinvestor.com/investornyt/1226809/jefferies-kalder-lundbecks-opkob-for-storre-end-ventet-bade-i-storrelse-og-pa-potentiale</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038166</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038166</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 14 Oct 2024 13:24:49 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Mon, 14 Oct 2024 10:33:02 GMT]]></title><description><![CDATA[<p dir="auto">Lundbecks topchef ser milliarderne rulle ind om seks år efter amerikansk opkøb <a href="https://proinvestor.com/investornyt/1226692/lundbecks-topchef-ser-milliarderne-rulle-ind-om-seks-ar-efter-amerikansk-opkob" rel="nofollow ugc">https://proinvestor.com/investornyt/1226692/lundbecks-topchef-ser-milliarderne-rulle-ind-om-seks-ar-efter-amerikansk-opkob</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038157</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038157</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 14 Oct 2024 10:33:02 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Mon, 14 Oct 2024 10:30:19 GMT]]></title><description><![CDATA[<p dir="auto">Lundbeck i historisk opkøb til 17 mia. kr. <a href="https://proinvestor.com/investornyt/1226670/lundbeck-i-historisk-opkob-til-17-mia-kr" rel="nofollow ugc">https://proinvestor.com/investornyt/1226670/lundbeck-i-historisk-opkob-til-17-mia-kr</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038153</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038153</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 14 Oct 2024 10:30:19 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Fri, 11 Oct 2024 03:07:01 GMT]]></title><description><![CDATA[<p dir="auto">Teva Pharma To Pay $450 Mln To Settle Kickback Allegations <a href="https://proinvestor.com/investornyt/1225702/teva-pharma-to-pay-450-mln-to-settle-kickback-allegations" rel="nofollow ugc">https://proinvestor.com/investornyt/1225702/teva-pharma-to-pay-450-mln-to-settle-kickback-allegations</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038149</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038149</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Fri, 11 Oct 2024 03:07:01 GMT</pubDate></item><item><title><![CDATA[Reply to Pharma — Oktober 2024 on Mon, 07 Oct 2024 11:33:22 GMT]]></title><description><![CDATA[<p dir="auto">Pfizer går grøn dag i møde efter aktivistinvestors aktiekøb for 1 mia. dollar <a href="https://proinvestor.com/investornyt/1223630/pfizer-gar-gron-dag-i-mode-efter-aktivistinvestors-aktiekob-for-1-mia-dollar" rel="nofollow ugc">https://proinvestor.com/investornyt/1223630/pfizer-gar-gron-dag-i-mode-efter-aktivistinvestors-aktiekob-for-1-mia-dollar</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/8038147</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/8038147</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 07 Oct 2024 11:33:22 GMT</pubDate></item></channel></rss>